Correction to: Nivolumab treatment beyond progressive disease in advanced non-small cell lung cancer
Clin. transl. oncol. (Print)
; 24(7)julio 2022.
Article
in En
| IBECS
| ID: ibc-203845
Responsible library:
ES1.1
Localization: ES15.1 - BNCS
ABSTRACT
In the original version of this article, the given names of all authors were omitted. The complete names were provided below.Takatoshi Enomoto, Akihiro Tamiya, Kinnosuke Matsumoto, Yuichi Adachi, Koji Azuma, Yuji Inagaki, Shunichi Kouno, Yoshihiko Taniguchi, Nobuhiko Saijo, Kyoichi Okishio, Shinji AtagiThe original article has been corrected.
Full text:
1
Collection:
06-national
/
ES
Database:
IBECS
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Lung Neoplasms
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Journal:
Clin. transl. oncol. (Print)
Year:
2022
Document type:
Article